Skip to main content
. 2020 Dec 31:pvaa138. doi: 10.1093/ehjcvp/pvaa138

Figure 4.

Figure 4

Severe/critical CoViD-19 in patients with history of hypertension. (A) Random effects meta-analysis. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; CoViD-19, coronavirus disease 2019. All studies were published in the year 2020. Definitions of severe and critical are detailed in Supplementary material online, Table S1 footnote. Liu Y (ACEi/ARB numbers manually calculated with assumption that no patients used ACEi and ARB at the same time). (B) Funnel plot. Egger’s test for small-study effects (14 studies): estimated bias coefficient −1.861, standard error 0.811, P-value = 0.041.